How to Respond to a Medicare ADR Letter for Freestanding Radiation Oncology Center: IMRT and SBRT Medical Necessity Documentation
Learn Medicare’s IMRT medical necessity criteria and SBRT billing distinctions and how to build a defensible ADR response.
KNOWLEDGE CENTER
7/30/20267 min read
Intensity-modulated radiation therapy and stereotactic body radiation therapy each represent more technically advanced radiation delivery approaches than conventional or three-dimensional conformal radiation therapy, and Medicare’s coverage of both technologies depends on documentation from the radiation oncologist establishing the specific clinical circumstances that make this more advanced approach medically reasonable and necessary for the particular patient. Because IMRT medical necessity is governed by a specific set of qualifying clinical scenarios, and because SBRT is billed under its own distinct code structure separate from conventional radiation therapy management codes, an ADR challenging either technology requires a response addressing the specific coverage standard applicable to that particular technology.
This article explains the IMRT medical necessity criteria and the clinical scenarios that do not typically support IMRT use, the distinct billing structure applicable to SBRT, why this documentation area draws sustained ADR attention, and how freestanding radiation oncology centers should structure an effective response when IMRT or SBRT medical necessity is challenged. It closes with how HealthBridge US supports Freestanding Radiation Oncology Centers strengthening IMRT and SBRT medical necessity documentation.
The IMRT Medical Necessity Standard
IMRT is considered medically reasonable and necessary when specific qualifying circumstances are present, including where an immediately adjacent area has been previously irradiated and abutting portals must be established with high precision, where dose escalation is planned to deliver radiation doses in excess of those commonly utilized for similar tumors with conventional treatment, or where the target volume is concave or convex with critical normal tissues located within or around that convexity or concavity. Documentation from the radiation oncologist must specifically establish which of these qualifying circumstances applies to the particular patient, and this documentation must be available when requested or submitted during the appeals process.
Clinical Scenarios That Do Not Typically Support IMRT
Certain clinical scenarios do not typically support IMRT use, including situations where conventional or three-dimensional conformal radiation therapy techniques can deliver good clinical outcomes with low toxicity, clinically urgent scenarios such as spinal cord compression, superior vena cava syndrome, or airway obstruction, palliative treatment of metastatic disease where the prescribed dose does not approach normal tissue tolerances, or an inability to account for organ motion, such as a mobile lung tumor. IMRT is not considered reasonable and necessary where at least one of the qualifying medical necessity criteria is not documented as present, meaning documentation should affirmatively address why the patient’s circumstances fall within a qualifying scenario rather than one of these non-qualifying scenarios.
SBRT’s Distinct Billing Structure
Stereotactic body radiation therapy is billed using its own distinct management codes, separate from the weekly treatment management codes applicable to conventional and IMRT courses of therapy, and these conventional weekly management codes should not be billed for stereotactic courses of therapy. Documentation should clearly identify when a course of treatment is being furnished as SBRT specifically, ensuring billing staff apply the correct, SBRT-specific management codes rather than the codes applicable to conventional or IMRT treatment courses.
Documenting the Clinical Basis for Choosing SBRT Over Conventional Approaches
Beyond the specific billing code distinction, documentation should reflect the clinical rationale for selecting SBRT as the treatment approach for a given patient, addressing factors such as tumor size, location, and the patient’s overall treatment goals that make this highly targeted, typically shorter-course approach clinically appropriate. This documentation should be maintained by the radiation oncologist as part of the treatment planning record, distinct from but complementary to the treatment planning documentation addressing the technical planning process itself.
Why IMRT and SBRT Medical Necessity Draws Sustained ADR Attention
Because IMRT and SBRT both represent more resource-intensive radiation delivery approaches than conventional radiation therapy, reviewing contractors examine whether documentation specifically establishes one of the qualifying IMRT medical necessity criteria, and whether SBRT is billed using the correct, technology-specific management codes rather than conventional weekly management codes. Reviewers may also specifically examine whether a patient’s clinical presentation falls within one of the non-qualifying scenarios described above, since documentation showing IMRT was used in one of these scenarios without addressing why the qualifying criteria nonetheless applied would not support medical necessity.
Building an Effective ADR Response
When an ADR challenges IMRT or SBRT medical necessity, the response should include the radiation oncologist’s specific documentation identifying which qualifying medical necessity criterion applies for an IMRT claim, or the clinical rationale supporting SBRT’s use alongside confirmation that the correct SBRT-specific billing codes were applied. Where a genuine documentation gap exists, such as treatment planning documentation that does not clearly articulate which specific IMRT qualifying criterion applies, the center should address this directly while providing whatever other contemporaneous clinical documentation may help establish the patient’s specific circumstances supported the technology used.
Common IMRT and SBRT Documentation Gaps
Several recurring gaps appear in this documentation area. IMRT claims supported only by a general statement that IMRT was medically necessary, without specifically identifying which qualifying criterion applies, represent a frequently cited issue. IMRT used in a clinical scenario resembling one of the non-qualifying situations, without documentation addressing why the qualifying criteria nonetheless applied, represents another significant gap, particularly in urgent treatment scenarios where documentation may be completed more hurriedly than in a scheduled, non-urgent course of care. SBRT courses billed using conventional weekly treatment management codes rather than the SBRT-specific management codes round out a frequent finding in this area, along with SBRT documentation that does not specifically address the tumor site’s particular clinical considerations.
Building a Recurring Internal Audit Addressing IMRT and SBRT Medical Necessity
Freestanding radiation oncology centers benefit from a recurring internal audit specifically sampling IMRT and SBRT patients, verifying that documentation clearly identifies the applicable IMRT qualifying criterion or SBRT clinical rationale, and that billing codes correctly correspond to the specific technology used. Centers should specifically flag any IMRT claim where the documented clinical scenario resembles one of the recognized non-qualifying situations, ensuring these claims receive closer scrutiny before submission, and should apply this same heightened review to SBRT claims involving less commonly treated tumor sites.
Training Radiation Oncologists on IMRT Qualifying Criteria Documentation
Because IMRT medical necessity depends on documentation specifically identifying one of a defined set of qualifying criteria, radiation oncologists should receive targeted training addressing this specific documentation requirement, ensuring treatment planning notes explicitly reference the applicable qualifying criterion rather than a general statement that IMRT was appropriate. Physicians who understand this specific documentation expectation are better positioned to generate contemporaneous records that clearly withstand a subsequent ADR review addressing IMRT medical necessity, rather than records that require reconstruction of the clinical reasoning well after the treatment itself was furnished.
Addressing Documentation for Patients With Multiple Potentially Qualifying Criteria
Some patients may present with clinical circumstances arguably supporting more than one of the IMRT qualifying criteria, such as a patient with both a previously irradiated adjacent area and a concave target volume involving critical structures. In these circumstances, documentation should specifically address whichever criteria genuinely apply to the patient’s presentation, providing a more robust medical necessity record than documentation addressing only a single criterion where multiple genuinely apply. This approach also provides a stronger foundation for an ADR response, since the response can draw on whichever specific criterion the reviewing contractor’s challenge focuses on, rather than relying on a single documented basis that the reviewer may specifically dispute.
Distinguishing IMRT Medical Necessity From General Treatment Preference
Because IMRT represents a more resource-intensive approach than conventional radiation therapy, documentation should specifically distinguish between a genuine clinical basis for IMRT under one of the recognized qualifying criteria and a general preference for IMRT based on convenience, patient request, or an assumption that more advanced technology is inherently superior regardless of the specific clinical circumstances. A radiation oncologist’s documentation should reflect that the decision to use IMRT was driven by the specific qualifying clinical criterion present, rather than a general institutional practice of defaulting to IMRT across a broad range of cases without regard to whether the specific qualifying circumstances are actually present, since a reviewing contractor examining a pattern of IMRT claims across many patients may specifically look for this kind of default-practice pattern.
Addressing SBRT Documentation for Extracranial and Intracranial Applications
SBRT may be furnished for both extracranial and intracranial tumor sites, and documentation should specifically address the tumor location and the clinical rationale supporting SBRT’s use at that specific site, since the technical requirements and clinical considerations can differ between these applications. A chart review addressing SBRT medical necessity should verify that documentation reflects site-specific clinical reasoning rather than a generic SBRT justification applied uniformly regardless of the specific tumor location being treated, since the technical and clinical considerations distinguishing an appropriate extracranial application from an appropriate intracranial application are genuinely distinct.
Building a Pre-Treatment Medical Necessity Checklist for IMRT Cases
Given how specifically IMRT medical necessity depends on documentation identifying one of a defined set of qualifying criteria, freestanding radiation oncology centers should implement a pre-treatment checklist prompting the radiation oncologist to specifically identify which qualifying criterion applies before treatment begins, rather than addressing this documentation requirement only retrospectively if a claim is later challenged. This proactive approach ensures the medical necessity determination is made and documented contemporaneously with the treatment planning process, producing a more clinically credible record than documentation reconstructed after the fact.
Coordinating IMRT and SBRT Documentation With Referring Physician Records
Because patients receiving IMRT or SBRT are often referred by another treating physician, such as a surgeon or medical oncologist, documentation from the referring physician addressing the patient’s overall treatment plan and the rationale for radiation therapy can provide valuable corroborating support for the radiation oncologist’s own medical necessity documentation. Centers should consider incorporating relevant referring physician documentation into the patient’s radiation oncology record where it directly supports the qualifying criteria applicable to that patient’s IMRT or SBRT course.
How HealthBridge US Supports Your Freestanding Radiation Oncology Center
IMRT medical necessity depends on documentation identifying one of a specific set of qualifying clinical criteria, while SBRT requires its own distinct, technology-specific billing approach separate from conventional radiation therapy management. HealthBridge US supports Freestanding Radiation Oncology Centers with IMRT medical necessity documentation audits, SBRT billing accuracy review, and ADR response support. If your center wants to strengthen IMRT and SBRT medical necessity documentation, verify billing code accuracy, or needs support responding to an active ADR, HealthBridge US is here to help — contact our team to discuss your center’s compliance needs.
References
• Centers for Medicare & Medicaid Services. “Local Coverage Determination: Radiation Therapies” (L39553). https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39553
• Centers for Medicare & Medicaid Services. “Billing and Coding: Radiation Therapies” (LCD L34652). https://downloads.cms.gov/medicare-coverage-database/lcd_attachments/34652_13/L34652_RAD014_BCG.pdf
• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 13 (Radiology Services and Other Diagnostic Procedures). https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/clm104c13.pdf
• Centers for Medicare & Medicaid Services. Medicare Physician Fee Schedule. https://www.cms.gov/medicare/payment/fee-schedules/physician
• Centers for Medicare & Medicaid Services. “Additional Documentation Request.” https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/medical-review-education/additional-documentation-request
• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 29 (Appeals). https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/clm104c29.pdf
HealthBridge US is here to help. Our compliance specialists support Freestanding Radiation Oncology Centers with IMRT and SBRT documentation review and Medicare ADR response — contact us to protect your center’s reimbursement.

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.
The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.
HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.
© 2026 HealthBridge US, a California corporation. All rights reserved.
For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance
Legal
Resources
Based in Los Angeles, California, operating in all 50 states.














